Search

everythinglearnresearchcommunity

for

Search:↓

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

New treatments show promise for hair loss, especially JAK inhibitors for alopecia areata.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Ivarmacitinib effectively regrows hair in severe alopecia areata.

Azathioprine is a safe and effective long-term treatment for severe alopecia areata, significantly improving hair regrowth.

A 29-year-old woman with symptoms of both lupus and rheumatoid arthritis improved with specific medications.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

The treatment was effective for lupus nephritis with manageable side effects.

Avacopan is generally safe, with some minor side effects like nausea and fatigue.

Latanoprost therapy potentially caused a woman's white hair to darken again.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

Baricitinib helps regrow hair in severe alopecia areata but has side effects like infections and headaches.

Low dose methotrexate does not increase hair fall and may reduce it.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Low-dose intralesional corticosteroid treatment led to rapid hair regrowth in localized alopecia areata.

A(1-7) treatment reduces symptoms of lupus in mice.

Polyglutamic acid is a valuable, sustainable ingredient for skincare and haircare products.

A new hydrogel treatment reduces inflammation and promotes hair growth in alopecia areata.

A new hydrogel treatment reduces inflammation and promotes hair growth in alopecia areata.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Adalimumab can cause complete hair loss in rare cases.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Mogamulizumab can cause hair loss and skin rashes.

Large doses of glucocorticoids are not suitable for general use in treating severe alopecia areata due to inconsistent results and risks.

Nirogacestat can cause severe skin issues like hidradenitis suppurativa.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.